Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2013
10/15/2013US8557238 EG-VEGF nucleic acids and polypeptides and methods of use
10/15/2013US8557231 Biodegradable poly(beta-amino esters) and uses thereof
10/15/2013CA2566326C Peritoneal dialysis solution
10/15/2013CA2533926C Methods and compositions for producing antigenic responses
10/10/2013WO2013152252A1 Combination anti-cancer therapy
10/10/2013WO2013152165A1 Methods for treating cancer using pi3k inhibitor and mek inhibitor
10/10/2013WO2013152034A1 Dosage and administration of monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
10/10/2013WO2013151913A1 Tyrosine kinase inhibitor combinations and their use
10/10/2013WO2013151638A1 Novel compositions of combinations of non-covalent dna binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment
10/10/2013WO2013151516A1 Film tablet formulations comprising cefuroxime axetil and clavulanic acid
10/10/2013WO2013151058A1 DNA CONTROLLING miR-140 EXPRESSION, AND SCREENING METHOD OF DRUGS USING SAID DNA
10/10/2013WO2013150277A1 Ophthalmic therapy
10/10/2013US20130267713 Hepatitis C Virus Inhibitors
10/10/2013US20130267591 Novel ophthalmic compositions
10/10/2013US20130267573 Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
10/10/2013US20130267549 Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis
10/10/2013US20130267548 Substituted 6-fluoro-1h-pyrazolo[4,3-b]pyridines and use thereof
10/10/2013US20130267502 Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
10/10/2013US20130267499 NOVEL TETRAHYDROPYRAZOLO [3,4-b] AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
10/10/2013US20130267498 Compounds useful as protein kinase inhibitors
10/10/2013US20130267497 Kinase inhibitors
10/10/2013US20130267492 Aryl sulfonamides
10/10/2013US20130267484 Treatment of rheumatoid arthritis with masitinib
10/10/2013US20130267475 Method of Treating Neurological Conditions with Oleandrin
10/10/2013US20130267460 Methods of Inhibiting Alphavirus Replication and Treating Alphavirus Infection
10/10/2013US20130267458 Compositions and uses of materials with high antimicrobial activity and low toxicity
10/10/2013US20130267456 Therapeutic applications of smad7
10/10/2013US20130266647 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
10/10/2013US20130266645 Derivatives of steroid benzylamines, having an antiparasitic antibacterial, antimycotic and/or antiviral action
10/10/2013US20130266643 Compositions comprising glyceryl-triacetate (GTA) and uses in human performance optimization and thermogenesis
10/10/2013US20130266639 METHODS FOR TREATING TRIPLE NEGATIVE BREAST CANCER USING BIFUNCTIONAL SRC 3 shRNA
10/10/2013US20130266599 Method for inducing an immune response against avian, swine, spanish, h1n1, h5n9 influenza viruses and formulations thereof
10/10/2013US20130266597 Small Cationic Antimicrobial Peptides
10/10/2013US20130266596 Novel benzodiazepine derivatives
10/10/2013US20130266591 Use of tri-substituted glycerol compounds for the treatment of hematological malignancies
10/10/2013US20130266590 Dimeric iap inhibitors
10/10/2013US20130266586 Method of Providing Disease-Specific Binding Molecules and Targets
10/10/2013US20130266585 Method of Providing Disease-Specific Binding Molecules and Targets
10/10/2013US20130266574 Human antibodies to human angiopoietin-like protein 4
10/10/2013US20130266573 Specific binding proteins and uses thereof
10/10/2013US20130266572 Nucleic acids targeting tctp for use in the treatment of chemo-or hormone- resistant cancers
10/10/2013US20130266569 Compositions and methods for diagnosing and treating cancer
10/10/2013US20130266563 Substituted 4-(selenophen-2(or-3)-ylamino)pyrimidine compounds and methods of use thereof
10/10/2013US20130266560 Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
10/10/2013US20130266549 Highly biocompatible dual thermogelling chitosan/glucosamine salt composition
10/10/2013US20130266538 Solid Forms of a Thiophosphoramidate Nucleotide Prodrug
10/10/2013US20130266537 Moesin modulators and uses thereof
10/10/2013US20130266534 Method for producing and using a copolymer of sodium carboxymethyl cellulose and gossypol
10/10/2013US20130266514 Method of Providing Disease-Specific Binding Molecules and Targets
10/10/2013US20130266510 Compositions and methods for treatment of drug resistant multiple myeloma
10/09/2013EP2647708A1 Marker for determination of sensitivity to triplet combination anti-cancer agent
10/09/2013EP2647397A1 Acidic concentrate for dialysis
10/09/2013EP2647384A1 IMMUNOTHERAPY USING ALLO-NKT CELLS, CELLS FOR IMMUNOTHERAPY IN WHICH CHAIN OF T-CELL RECEPTOR (TCR) GENE HAS BEEN REARRANGED TO UNIFORM Va-Ja , AND BANKING OF NKT CELLS DERIVED FROM SAID CELLS
10/09/2013EP2646044A1 Methods for increasing intracellular activity of hsp70
10/09/2013EP2646033A1 Volasertib alone or in combination with cytarabine for treating acute myeloid leukemia
10/09/2013EP2646019A1 Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
10/09/2013EP2101780B1 Methods of treating chronic inflammatory diseases using a gm-csf antagonist
10/09/2013CN103347521A Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer
10/09/2013CN103347514A FGFR1 extracellular domain combination therapies
10/09/2013CN103347511A Potentiator of antitumor activity of chemotherapeutic agent
10/09/2013CN103347507A Melatonin and an antimicrobial or antibacterial agent for the treatment of acne
10/09/2013CN103347495A Combination of opioid agonist and opioid antagonist in treatment of parkinson's disease
10/09/2013CN103342700A 11[beta]-hydroxysteroid dehydrogenase type 1 inhibitor
10/09/2013CN103341177A Reduction sensitive type polyethylene glycol-medicament conjugate and preparation method thereof
10/09/2013CN103341168A Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or Flt1 antagonist for treating cancer
10/09/2013CN103341167A Compound acetic acid solution for veterinary use and preparation process of compound acetic acid solution
10/09/2013CN103340860A Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
10/09/2013CN102440961B Targeting polymer micelle containing acid-sensitive subsurface, and preparation method thereof
10/09/2013CN102366428B Applications of extracts from Chinese herbal medicine Oroxylum indicum in preparation of slimming and lipid lowering medicine or preparation of medicine with inhibition effect on activity of lipase
10/09/2013CN102266569B Application of miR-199a and inhibitor thereof
10/08/2013US8552165 Immunostimulatory oligonucleotides
10/08/2013US8552025 Stable methylnaltrexone preparation
10/08/2013US8552015 Quinazolinone derivatives and their use as CB agonists
10/08/2013US8551977 Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
10/08/2013US8551967 Formulations with anti-tumour action
10/08/2013US8551554 Phytochemical preservation, drying and grinding; maintaining high phenolic and flavonoid content; antioxidative and antiproliferative properties
10/08/2013US8551498 Solid composition containing Bacillus-type non-pathogenic bacterial spores
10/08/2013US8551490 Genetic products differentially expressed in tumors and use thereof
10/08/2013US8551462 Cosmetic composition and method for retarding hair growth
10/08/2013CA2495048C Hemostatic compositions and devices
10/08/2013CA2453403C Methods of inhibiting amyloid toxicity
10/08/2013CA2382817C Use of fibrin or fibrinogen for reducing lung tissue volume
10/08/2013CA2380753C Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor
10/08/2013CA2349839C Ucp5
10/08/2013CA2238893C Il-13 receptor polypeptide
10/03/2013WO2013148919A1 Treatment of multiple myeloma
10/03/2013WO2013148072A1 Administration of eritoran or pharmaceutically acceptable salts thereof to treat orthomyxovirus infections
10/03/2013WO2013147649A2 Inhibitors of the pi3k/akt/ikk/nf-kb signalling pathway, pharmaceutically acceptable salts thereof and compositions containing said inhibitors for the prophylaxis and treatment of viral diseases
10/03/2013WO2013147212A1 Novel anti-siglec15 antibody
10/03/2013WO2013147137A1 Therapeutic agent for cardiac failure
10/03/2013WO2013147076A1 FIBROSIS SUPPRESSION BY INHIBITING INTEGRIN α8β1 FUNCTION
10/03/2013WO2013146914A1 Inspection method of brain infarction using kallistatin protein
10/03/2013WO2013146911A1 Prophylactic or therapeutic agent for diabetes
10/03/2013WO2013146435A1 Agent for preventing or treating giant cell tumor or chondrosarcoma arising in bone/soft tissue
10/03/2013WO2013144923A1 Administration of a raf inhibitor and a mek inhibitor in the treatment of melanoma
10/03/2013WO2013143299A1 Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof
10/03/2013US20130261181 Molecules to Perfect HbA1c Levels
10/03/2013US20130261177 Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest
10/03/2013US20130261137 Methods, Compounds and Compositions Relating to Activating a Latent Virus
10/03/2013US20130261135 Metalloenzyme inhibitor compounds
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 1151